Switch to:
More From Other Websites
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 18 2017
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 17 2017
VIVUS Licenses Rights to PAH Drugs from Selten Pharma Jan 11 2017
VIVUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 10 2017
VIVUS INC Files SEC form 8-K, Other Events Jan 09 2017
VIVUS and Selten Pharma Announce Agreement for the Development and Commercialization Rights to... Jan 09 2017
VIVUS (VVUS): Will Qsymia & Stendra Sales Improve in 2017? Jan 03 2017
ETFs with exposure to VIVUS, Inc. : December 27, 2016 Dec 27 2016
Do Hedge Funds Love VIVUS, Inc. (VVUS)? Dec 14 2016
ETFs with exposure to VIVUS, Inc. : December 13, 2016 Dec 13 2016
Increased Earnings Estimates Seen for VIVUS (VVUS): Can It Move Higher? Dec 05 2016
VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session Nov 21 2016
ETFs with exposure to VIVUS, Inc. : November 18, 2016 Nov 18 2016
VIVUS INC Financials Nov 17 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters... Nov 14 2016
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
VIVUS (VVUS) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Edited Transcript of VVUS earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to... Nov 09 2016
VIVUS Reports 2016 Third Quarter Financial Results Nov 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK